- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin Glargine (HOE901) [Lantus]
Total 593 results
-
Population Health Research InstituteCompletedHyperglycemia | Myocardial Infarction | Cardiovascular DiseasesArgentina, Canada, India
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityUnknown
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Cairo UniversityCompletedDiabetes Mellitus (DM)Egypt
-
HealthPartners InstituteSanofi; International Diabetes Center at Park NicolletCompletedHyperglycemiaUnited States
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Completed
-
Eli Lilly and CompanyCompletedDiabetes MellitusSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
Eli Lilly and CompanyCompleted
-
University of Sao Paulo General HospitalCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseBrazil
-
Guillermo UmpierrezCompleted
-
SanofiTerminated
-
Eli Lilly and CompanyCompleted
-
Emory UniversityNovo Nordisk A/SCompletedType 2 DiabetesUnited States
-
Servier (Tianjin) Pharmaceutical Co. LTD.Completed
-
Merck Sharp & Dohme LLCCompleted
-
Joslin Diabetes CenterEli Lilly and Company; Amylin Pharmaceuticals, LLC.CompletedType 2 Diabetes MellitusUnited States
-
Boston Medical CenterNovo Nordisk A/SCompletedType 2 Diabetes Treated With InsulinUnited States
-
SanofiCompletedDiabetes MellitusUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
University of Colorado, DenverCompletedType 1 Diabetes Mellitus | Diabetic KetoacidosisUnited States
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Weill Cornell Medical College in QatarNovo Nordisk A/STerminated
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type IIUnited States
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Centre hospitalier de l'Université de Montréal...Radiological Society of North America; Centre de Recherche du Centre Hospitalier... and other collaboratorsCompletedStudy of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes (LIRAINS)Type 2 Diabetes | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisCanada
-
Fundación Pública Andaluza Progreso y SaludCompleted
-
Cairo UniversitySanofiUnknownLiver Cirrhosis | Type 2 DiabetesEgypt
-
The First Affiliated Hospital of Xiamen UniversityUnknownOverweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes PatientsChina
-
Providence Health & ServicesWithdrawn
-
Fudan UniversityShanghai Changzheng Hospital; Shanghai 6th People's Hospital; Shanghai Minhang... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Non-alcoholic Fatty Liver DiseaseChina
-
AstraZenecaEli Lilly and CompanyCompleted
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Completed
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Nordsjaellands HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedType 1 Diabetes Mellitus | Nocturnal Hypoglycemia | Recurrent Severe HypoglycaemiaDenmark
-
University Hospital TuebingenWithdrawn
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
SanofiTerminatedDiabetes Mellitus, Type 2Netherlands
-
Institut de Recherches Cliniques de MontrealNovo Nordisk A/S; McMaster UniversityCompleted